Symbiomix Therapeutics, LLC

Home  Symbiomix Therapeutics, LLC

  • LifeSciences
105 Lock Street #409
Newark, NJ 07103
(609) 722-7250
  • About

    Symbiomix is a late-stage, privately held biopharmaceutical company with a focus on women’s health. The company’s lead product, SYM-1219, is a new anti-infective drug being studied as the first oral one-and-done treatment in the United States for bacterial vaginosis (BV), a common but underappreciated gynecological infection that greatly increases the risk of serious health problems.